Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Sci Rep ; 10(1): 11542, 2020 07 09.
Artigo em Inglês | MEDLINE | ID: mdl-32647146

RESUMO

Hypovitaminosis D has been linked to several non-bone diseases. Relation between 25-hydroxyvitamin D [25(OH)D] and lung function and lung diseases has received little attention at the global level. Cross-sectional data from three National Health and Nutrition Examination Surveys, 2007-2008, 2009-2010, and 2011-2012 were used to investigate the relationship between serum 25(OH)D concentrations and lung function makers [forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1)] and lung diseases (asthma, emphysema, and chronic bronchitis) with multivariate regression models (n = 11,983; men, 6,010; women, 5,973). Serum 25(OH)D concentrations were directly associated with FVC and FEV1 (P for trend < 0.01). Individuals in the 4th quartile serum 25(OH)D had significantly higher FVC and FEV1 compared to those in the 1st quartile (P < 0.01). When data were stratified based on gender and smoking status, we found similar associations between serum 25(OH)D concentrations and lung function markers. There was no relation between serum 25(OH)D and prevalence of asthma, chronic bronchitis, and emphysema in US adults. Serum 25(OH)D concentration is associated with improved lung function markers but not with the prevalence of asthma, emphysema, and chronic bronchitis. Controlled studies are needed to determine if the vitamin D supplementation improves lung function in adults and in smokers.


Assuntos
Asma/sangue , Bronquite/sangue , Pulmão/fisiopatologia , Enfisema Pulmonar/sangue , Vitamina D/análogos & derivados , Adulto , Idoso , Idoso de 80 Anos ou mais , Asma/epidemiologia , Bronquite/epidemiologia , Doença Crônica , Fatores de Confusão Epidemiológicos , Estudos Transversais , Etnicidade/estatística & dados numéricos , Feminino , Seguimentos , Volume Expiratório Forçado , Inquéritos Epidemiológicos , Humanos , Masculino , Pessoa de Meia-Idade , Gravidez , Complicações na Gravidez/sangue , Complicações na Gravidez/epidemiologia , Prevalência , Enfisema Pulmonar/epidemiologia , Fumar/sangue , Fumar/epidemiologia , Estados Unidos/epidemiologia , Capacidade Vital , Vitamina D/sangue , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/epidemiologia
2.
Artigo em Inglês | MEDLINE | ID: mdl-32103933

RESUMO

Alpha-1 antitrypsin deficiency (AATD) is a rare and underdiagnosed genetic predisposition for COPD and emphysema and other conditions, including liver disease. Although there have been improvements in terms of awareness of AATD and understanding of its treatment in recent years, current challenges center on optimizing detection and management of patients with AATD, and improving access to intravenous (IV) AAT therapy - the only available pharmacological intervention that can slow disease progression. However, as an orphan disease with geographically dispersed patients, international cooperation is essential to address these issues. To achieve this, new European initiatives in the form of the European Reference Network for Rare Lung Diseases (ERN-LUNG) and the European Alpha-1 Research Collaboration (EARCO) have been established. These organizations are striving to address the current challenges in AATD, and provide a new platform for future research efforts in AATD. The first objectives of ERN-LUNG are to establish a quality control program for European AATD laboratories and create a disease management program for AATD, following the success of such programs in the United States. The main purpose of EARCO is to create a pan-European registry, with the aim of understanding the natural history of the disease and supporting the development of new treatment modalities in AATD and access to AAT therapy. Going further, other patient-centric initiatives involve improving the convenience of intravenous AAT therapy infusions through extended-interval dosing and self-administration. The present review will discuss the implementation of these initiatives and their potential contribution to the optimization of patient care in AATD.


Assuntos
Terapia de Reposição de Enzimas , Assistência Centrada no Paciente , Doença Pulmonar Obstrutiva Crônica/terapia , Enfisema Pulmonar/terapia , Deficiência de alfa 1-Antitripsina/terapia , alfa 1-Antitripsina/administração & dosagem , Terapia de Reposição de Enzimas/efeitos adversos , Humanos , Infusões Intravenosas , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Enfisema Pulmonar/diagnóstico , Enfisema Pulmonar/epidemiologia , Qualidade de Vida , Resultado do Tratamento , alfa 1-Antitripsina/efeitos adversos , Deficiência de alfa 1-Antitripsina/diagnóstico , Deficiência de alfa 1-Antitripsina/epidemiologia
3.
Am J Ind Med ; 61(4): 308-316, 2018 04.
Artigo em Inglês | MEDLINE | ID: mdl-29424024

RESUMO

INTRODUCTION: A cohort of Gulf War I veterans who sustained exposure to depleted uranium undergoes biennial surveillance for potential uranium-related health effects. We performed impulse oscillometry and hypothesized that veterans with higher uranium body burdens would have more obstructive abnormalities than those with lower burdens. METHODS: We compared pulmonary function of veterans in high versus low urine uranium groups by evaluating spirometry and oscillometry values. RESULTS: Overall mean spirometry and oscillometry resistance values fell within the normal ranges. There were no significant differences between the high and low uranium groups for any parameters. However, more veterans were classified as having obstruction by oscillometry (42%) than spirometry (8%). CONCLUSIONS: While oscillometry identified more veterans as obstructed, obstruction was not uranium-related. However, the added sensitivity of this method implies a benefit in wider surveillance of exposed cohorts and holds promise in identifying abnormalities in areas of the lung historically described as silent.


Assuntos
Guerra do Golfo , Pulmão/fisiopatologia , Exposição Ocupacional/estatística & dados numéricos , Doenças Respiratórias/epidemiologia , Urânio , Veteranos/estatística & dados numéricos , Adulto , Asma/epidemiologia , Asma/fisiopatologia , Bronquite/epidemiologia , Bronquite/fisiopatologia , Estudos de Coortes , Tosse/epidemiologia , Tosse/fisiopatologia , Dispneia/epidemiologia , Dispneia/fisiopatologia , Volume Expiratório Forçado , Humanos , Pessoa de Meia-Idade , Oscilometria , Enfisema Pulmonar/epidemiologia , Enfisema Pulmonar/fisiopatologia , Testes de Função Respiratória , Doenças Respiratórias/fisiopatologia , Espirometria , Capacidade Vital
4.
Poumon Coeur ; 32(3): 127-30, 1976.
Artigo em Francês | MEDLINE | ID: mdl-951350

RESUMO

Because of the high frequency of chronic cor pulmonale in workers admitted to the cardiology department of the Khazaneh Hospital in Teheran, we studied the clinical aspect and the risk factors of this disease in 66 male patients. The average age of patients was 56.1 years and they often had a long history of bronchitis isolated or associated with emphysema. The ECG analysis showed that most abnormalities were localized on the QRST wave. Tobacco and a polluted working environment were the factors most frequently met in our patients. The opium habit probably acted as a risk factor for chronic bronchopneumopathy, but further studies are necessary to ascertain the fact.


Assuntos
Doenças Profissionais/epidemiologia , Doença Cardiopulmonar/epidemiologia , Adulto , Idoso , Bronquite/epidemiologia , Doença Crônica , Humanos , Irã (Geográfico) , Masculino , Pessoa de Meia-Idade , Ópio , Enfisema Pulmonar/epidemiologia , Doença Cardiopulmonar/diagnóstico , Risco , Fumar , Fatores Socioeconômicos , Transtornos Relacionados ao Uso de Substâncias , Trabalho
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA